SynthesisFrontiers in microbiology2026
Evolutionary dynamics and research hotspots of phage applications against
Synthesis in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: Core bibliographic data were retrieved from the Web of Science Core Collection, Scopus, and PubMed databases. Following rigorous literature screening based on predefined inclusion and exclusion criteria, mainstream bibliometric analysis tools, including VOSviewer and CiteSpace, were comprehensively deployed to map and analyze the temporal dynamics of publication outputs, international collaboration networks among countries, institutions, authors, and journals, reference co-citation matrices, and keyword co-occurrence configurations, alongside timeline visualizations and citation burst detection, thereby systematically delineating the evolutionary blueprint of this research domain. Results: A total of 1,275 valid original publications were ultimately enrolled. Chronologically, the global annual publication volume exhibited a pronounced exponential growth trajectory ( Conclusion: Over the past two decades, research has expanded exponentially, with the knowledge architecture transitioning from descriptive biological characterization to deep genetic mechanisms and engineering-driven design. Future efforts should prioritize elucidating the molecular mechanisms of phage resistance, optimizing lytic enzyme efficacy, and accelerating multicenter translational interventions to combat multi-drug resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.